A review of computational and mathematical modeling contributions to our understanding of Mycobacterium tuberculosis within-host infection and treatment.
暂无分享,去创建一个
Denise Kirschner | Simeone Marino | Elsje Pienaar | Jennifer J Linderman | D. Kirschner | S. Marino | J. Linderman | E. Pienaar | Simeone Marino
[1] P. Andersen,et al. The success and failure of BCG — implications for a novel tuberculosis vaccine , 2005, Nature Reviews Microbiology.
[2] W. Garira,et al. THE ROLE OF DENDRITIC CELLS AND OTHER IMMUNE MECHANISMS DURING HUMAN INFECTION WITH MYCOBACTERIUM TUBERCULOSIS , 2009 .
[3] A. Barth,et al. Population pharmacokinetics and its role in anti-tuberculosis drug development and optimization of treatment. , 2011, Current pharmaceutical design.
[4] JoAnne L. Flynn,et al. Experimental Mycobacterium tuberculosis Infection of Cynomolgus Macaques Closely Resembles the Various Manifestations of Human M. tuberculosis Infection , 2003, Infection and Immunity.
[5] Nicola J. Mulder,et al. Predicting and Analyzing Interactions between Mycobacterium tuberculosis and Its Human Host , 2013, PloS one.
[6] A. Friedman,et al. Modeling Granulomas in Response to Infection in the Lung , 2016, PloS one.
[7] I. Orme,et al. Chemokine response in mice infected with Mycobacterium tuberculosis , 1995, Infection and immunity.
[8] P. Cardona,et al. The Small Breathing Amplitude at the Upper Lobes Favors the Attraction of Polymorphonuclear Neutrophils to Mycobacterium tuberculosis Lesions and Helps to Understand the Evolution toward Active Disease in An Individual-Based Model , 2016, Front. Microbiol..
[9] T. Ottenhoff,et al. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis , 2016, European Respiratory Journal.
[10] C. Castillo-Chavez,et al. A model for tuberculosis with exogenous reinfection. , 2000, Theoretical population biology.
[11] Simeone Marino,et al. Understanding the Immune Response in Tuberculosis Using Different Mathematical Models and Biological Scales , 2005, Multiscale Model. Simul..
[12] John Chan,et al. Depletion of Cd4+ T Cells Causes Reactivation of Murine Persistent Tuberculosis despite Continued Expression of Interferon γ and Nitric Oxide Synthase 2 , 2000, The Journal of experimental medicine.
[13] J. Flynn,et al. Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension , 2006, Cellular microbiology.
[14] Shayn M Peirce,et al. Multiscale computational models of complex biological systems. , 2013, Annual review of biomedical engineering.
[15] S. Behar,et al. In Vivo Depletion of CD11c+ Cells Delays the CD4+ T Cell Response to Mycobacterium tuberculosis and Exacerbates the Outcome of Infection1 , 2005, The Journal of Immunology.
[16] Siv Jönsson,et al. Population Pharmacokinetics of Ethambutol in South African Tuberculosis Patients , 2011, Antimicrobial Agents and Chemotherapy.
[17] P. Andersen,et al. Tuberculosis vaccines--rethinking the current paradigm. , 2014, Trends in immunology.
[18] Denise Kirschner,et al. A population model capturing dynamics of tuberculosis granulomas predicts host infection outcomes. , 2015, Mathematical biosciences and engineering : MBE.
[19] Wolfgang Wiechert,et al. 13C-Flux Spectral Analysis of Host-Pathogen Metabolism Reveals a Mixed Diet for Intracellular Mycobacterium tuberculosis , 2013, Chemistry & biology.
[20] M. Zimmerman,et al. Mass spectrometry imaging of levofloxacin distribution in TB-infected pulmonary lesions by MALDI-MSI and continuous liquid microjunction surface sampling. , 2015, International journal of mass spectrometry.
[21] J. Flynn,et al. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. , 1999, Journal of immunology.
[22] J. Flynn,et al. CCR5-Deficient Mice Control Mycobacterium tuberculosis Infection despite Increased Pulmonary Lymphocytic Infiltration1 , 2004, The Journal of Immunology.
[23] Elihu Aranday-Cortes,et al. Biomarkers of tuberculosis: a research roadmap. , 2013, Biomarkers in medicine.
[24] Johnjoe McFadden,et al. Carbon flux rerouting during Mycobacterium tuberculosis growth arrest , 2010, Molecular microbiology.
[25] J. Flynn,et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies , 2009, Nature Reviews Microbiology.
[26] C. Saltini. Schedule or dosage? The need to perfect intermittent regimens for tuberculosis. , 2006, American journal of respiratory and critical care medicine.
[27] J. Flynn,et al. In Situ Studyof Abundant Expression of Proinflammatory Chemokines and Cytokines inPulmonary Granulomas That Develop in Cynomolgus MacaquesExperimentally Infected with Mycobacteriumtuberculosis , 2003, Infection and Immunity.
[28] J. Stark,et al. Systems biology of persistent infection: tuberculosis as a case study , 2008, Nature Reviews Microbiology.
[29] A. Anderson,et al. Hybrid models of tumor growth , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.
[30] Robert J Woods,et al. How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient , 2017, PLoS biology.
[31] Mario Roederer,et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major , 2007, Nature Medicine.
[32] I. Orme,et al. Evaluation of Standard Chemotherapy in the Guinea Pig Model of Tuberculosis , 2010, Antimicrobial Agents and Chemotherapy.
[33] K. Dooley,et al. Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug , 2014, The Journal of antimicrobial chemotherapy.
[34] J. Flynn,et al. CD4(+) regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis infection. , 2010, The Journal of infectious diseases.
[35] Venkat Venkatasubramanian,et al. A systematic framework for the design of reduced-order models for signal transduction pathways from a control theoretic perspective , 2006, Comput. Chem. Eng..
[36] Simeone Marino,et al. Computational Modeling Predicts IL-10 Control of Lesion Sterilization by Balancing Early Host Immunity–Mediated Antimicrobial Responses with Caseation during Mycobacterium tuberculosis Infection , 2015, The Journal of Immunology.
[37] J. Flynn,et al. Long-Term Control of Mycobacterium tuberculosis Infection Is Mediated by Dynamic Immune Responses1 , 2005, The Journal of Immunology.
[38] J. L. Fuentes-Allen,et al. Within-host population dynamics of antibiotic-resistant M. tuberculosis. , 2007, Mathematical medicine and biology : a journal of the IMA.
[39] J. Casanova,et al. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. , 2008, The Journal of allergy and clinical immunology.
[40] W. Garira,et al. MATHEMATICAL MODELING OF CHEMOTHERAPY OF HUMAN TB INFECTION , 2006 .
[41] W. Garira,et al. Modelling the human immune response mechanisms to mycobacterium tuberculosis infection in the lungs. , 2006, Mathematical biosciences and engineering : MBE.
[42] A. Myers,et al. Early Events in Mycobacterium tuberculosis Infection in Cynomolgus Macaques , 2006, Infection and Immunity.
[43] H. McShane,et al. TB vaccines in clinical development. , 2016, Tuberculosis.
[44] S. Behar,et al. Cytolytic CD8+ T Cells Recognizing CFP10 Are Recruited to the Lung after Mycobacterium tuberculosis Infection , 2004, The Journal of experimental medicine.
[45] T. Randall,et al. In a Murine Tuberculosis Model, the Absence of Homeostatic Chemokines Delays Granuloma Formation and Protective Immunity1 , 2009, The Journal of Immunology.
[46] JoAnne L. Flynn,et al. Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model , 2009, Infection and Immunity.
[47] A. Dirksen,et al. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. , 2002, The Journal of infectious diseases.
[48] Antonio Bru,et al. Mathematical Modeling of Tuberculosis Bacillary Counts and Cellular Populations in the Organs of Infected Mice , 2010, PloS one.
[49] A. Rudensky,et al. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis , 2007, The Journal of experimental medicine.
[50] Simeone Marino,et al. A multifaceted approach to modeling the immune response in tuberculosis , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.
[51] Alimuddin Zumla,et al. Immunological biomarkers of tuberculosis , 2011, Nature Reviews Immunology.
[52] J. Flynn,et al. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[53] Elsje Pienaar,et al. A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment. , 2015, Journal of theoretical biology.
[54] R. Jelliffe,et al. Population Modeling and Simulation Study of the Pharmacokinetics and Antituberculosis Pharmacodynamics of Isoniazid in Lungs , 2015, Antimicrobial Agents and Chemotherapy.
[55] L. Ramakrishnan,et al. Superinfecting mycobacteria home to established tuberculous granulomas , 2004, Nature Immunology.
[56] J. Flynn,et al. Immunology studies in non‐human primate models of tuberculosis , 2015, Immunological reviews.
[57] S. Kaufmann,et al. Cutting Edge: Regulatory T Cells Prevent Efficient Clearance of Mycobacterium tuberculosis , 2007, The Journal of Immunology.
[58] Simeone Marino,et al. Tuneable resolution as a systems biology approach for multi-scale, multi-compartment computational models , 2014, Wiley interdisciplinary reviews. Systems biology and medicine.
[59] Maya Gough,et al. An in silico model of the effects of vitamin D3 on mycobacterium infected macrophage , 2016, 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).
[60] Indrani Bose,et al. Phenotypic heterogeneity in mycobacterial stringent response , 2010, BMC Systems Biology.
[61] M. Fallahi-Sichani,et al. NF-κB Signaling Dynamics Play a Key Role in Infection Control in Tuberculosis , 2012, Front. Physio..
[62] D. Kirschner,et al. Contribution of CD8+ T Cells to Control of Mycobacterium tuberculosis Infection1 , 2006, The Journal of Immunology.
[63] M. Chase,et al. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection , 2011, Nature Genetics.
[64] D. Kirschner,et al. Strategic Priming with Multiple Antigens can Yield Memory Cell Phenotypes Optimized for Infection with Mycobacterium tuberculosis: A Computational Study , 2016, Front. Microbiol..
[65] E. Coccia,et al. Bystander inhibition of dendritic cell differentiation by Mycobacterium tuberculosis‐induced IL‐10 , 2011, Immunology and cell biology.
[66] Simeone Marino,et al. Macrophage Polarization Drives Granuloma Outcome during Mycobacterium tuberculosis Infection , 2014, Infection and Immunity.
[67] D. Kirschner,et al. Macrophage response to Mycobacteriumtuberculosis infection , 2004, Journal of mathematical biology.
[68] G. Clermont,et al. Mathematical models of the acute inflammatory response , 2004, Current opinion in critical care.
[69] M. Delbrück,et al. Mutations of Bacteria from Virus Sensitivity to Virus Resistance. , 1943, Genetics.
[70] William R. Jacobs,et al. A Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis , 2009, PLoS pathogens.
[71] J. Flynn,et al. The Chemokine Receptor CXCR3 Attenuates the Control of Chronic Mycobacterium tuberculosis Infection in BALB/c Mice1 , 2007, The Journal of Immunology.
[72] C. Bauch,et al. An antibiotic protocol to minimize emergence of drug-resistant tuberculosis , 2014 .
[73] Claire E. Dodd,et al. New concepts in understanding latent tuberculosis , 2017, Current opinion in infectious diseases.
[74] G. Günther,et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a review of current concepts and future challenges. , 2014, Clinical medicine.
[75] Denise E Kirschner,et al. Multiple mechanisms allow Mycobacterium tuberculosis to continuously inhibit MHC class II-mediated antigen presentation by macrophages. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[76] H. McIlleron,et al. Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients. , 2011, British journal of clinical pharmacology.
[77] D. Kirschner,et al. Inoculation Dose of Mycobacterium tuberculosis Does Not Influence Priming of T Cell Responses in Lymph Nodes , 2013, The Journal of Immunology.
[78] James A. Raleigh,et al. Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates , 2008, Infection and Immunity.
[79] Mohammad Fallahi-Sichani,et al. Identification of Key Processes that Control Tumor Necrosis Factor Availability in a Tuberculosis Granuloma , 2010, PLoS Comput. Biol..
[80] S. Subramaniam,et al. Reduced-order modelling of biochemical networks: application to the GTPase-cycle signalling module. , 2005, Systems biology.
[81] J. Grosset,et al. Treatment of tuberculosis and optimal dosing schedules , 2010, Thorax.
[82] Simeone Marino,et al. A Multi-Compartment Hybrid Computational Model Predicts Key Roles for Dendritic Cells in Tuberculosis Infection , 2016, Comput..
[83] Denise Kirschner,et al. A Model to Predict Cell-Mediated Immune Regulatory Mechanisms During Human Infection with Mycobacterium tuberculosis1 , 2001, The Journal of Immunology.
[84] Joel S. Bader,et al. Multiscale Model of Mycobacterium tuberculosis Infection Maps Metabolite and Gene Perturbations to Granuloma Sterilization Predictions , 2016, Infection and Immunity.
[85] F. Sallusto. The role of chemokines and chemokine receptors in T cell priming and Th1/Th2-mediated responses. , 1999, Haematologica.
[86] J. Valls,et al. Local Inflammation, Dissemination and Coalescence of Lesions Are Key for the Progression toward Active Tuberculosis: The Bubble Model , 2016, Front. Microbiol..
[87] Simeone Marino,et al. Multiscale Computational Modeling Reveals a Critical Role for TNF-α Receptor 1 Dynamics in Tuberculosis Granuloma Formation , 2011, The Journal of Immunology.
[88] Jeong Su Cho,et al. Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives. , 2015, ACS infectious diseases.
[89] Alimuddin Zumla,et al. FOXP3 gene expression in a tuberculosis case contact study , 2007, Clinical and experimental immunology.
[90] V. Dartois. The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells , 2014, Nature Reviews Microbiology.
[91] J. Flynn,et al. Mycobacterium tuberculosis in Chemokine Receptor 2-Deficient Mice: Influence of Dose on Disease Progression , 2002, Infection and Immunity.
[92] S. Behar,et al. Antigen-Specific CD8+ T Cells and the Development of Central Memory during Mycobacterium tuberculosis Infection1 , 2006, The Journal of Immunology.
[93] A. Friedman,et al. Granuloma formation in leishmaniasis: A mathematical model. , 2017, Journal of theoretical biology.
[94] Matthew D. Zimmerman,et al. The association between sterilizing activity and drug distribution into tuberculosis lesions , 2015, Nature Medicine.
[95] P. Moodley,et al. Population Pharmacokinetics and Pharmacodynamics of Ofloxacin in South African Patients with Multidrug-Resistant Tuberculosis , 2012, Antimicrobial Agents and Chemotherapy.
[96] Denise E. Kirschner,et al. In silico evaluation and exploration of antibiotic tuberculosis treatment regimens , 2015, BMC Systems Biology.
[97] B. Levin,et al. Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[98] Scott L Diamond,et al. Multiscale prediction of patient-specific platelet function under flow. , 2012, Blood.
[99] Brian G. Williams,et al. Natural History of Tuberculosis: Duration and Fatality of Untreated Pulmonary Tuberculosis in HIV Negative Patients: A Systematic Review , 2011, PloS one.
[100] K. Dooley,et al. Phase I Safety, Pharmacokinetics, and Pharmacogenetics Study of the Antituberculosis Drug PA-824 with Concomitant Lopinavir-Ritonavir, Efavirenz, or Rifampin , 2014, Antimicrobial Agents and Chemotherapy.
[101] John Chan,et al. Differences in Reactivation of Tuberculosis Induced from Anti-TNF Treatments Are Based on Bioavailability in Granulomatous Tissue , 2007, PLoS Comput. Biol..
[102] Alimuddin Zumla,et al. Tuberculosis 2013 : 2 Tuberculosis biomarkers discovery : developments , needs , and challenges , 2013 .
[103] R. Wilkinson,et al. The ongoing challenge of latent tuberculosis , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.
[104] Steven J. Plimpton,et al. Oxygen Modulates the Effectiveness of Granuloma Mediated Host Response to Mycobacterium tuberculosis: A Multiscale Computational Biology Approach , 2016, Front. Cell. Infect. Microbiol..
[105] Marc Lipsitch,et al. Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug resistant tuberculosis , 2013, Nature Genetics.
[106] C. Bhunu,et al. Modelling the effects of pre-exposure and post-exposure vaccines in tuberculosis control. , 2008, Journal of theoretical biology.
[107] Debashis Ghosh,et al. Peptide length-based prediction of peptide-MHC class II binding , 2006, Bioinform..
[108] JoAnne L. Flynn,et al. Radiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy Regimens , 2013, Antimicrobial Agents and Chemotherapy.
[109] Simeone Marino,et al. TNF and IL-10 are major factors in modulation of the phagocytic cell environment in lung and lymph node in tuberculosis: a next-generation two-compartmental model. , 2010, Journal of theoretical biology.
[110] Nicolas Perry,et al. Toward a multiscale model of antigen presentation in immunity , 2007, Immunological reviews.
[111] Bernhard O. Palsson,et al. Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets , 2007 .
[112] Chang Gong,et al. A multi-scale approach to designing therapeutics for tuberculosis. , 2015, Integrative biology : quantitative biosciences from nano to macro.
[113] J. Flynn,et al. CD4+ T Cells Are Required for the Development of Cytotoxic CD8+ T Cells During Mycobacterium tuberculosis Infection1 , 2001, The Journal of Immunology.
[114] D. Kirschner,et al. The Effects of HIV-1 Infection on Latent Tuberculosis , 2008 .
[115] Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rβ1 isoform that enhances DC migration , 2010, The Journal of experimental medicine.
[116] S. Cole,et al. New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. , 2014, The Lancet. Infectious diseases.
[117] Simeone Marino,et al. Variability in Tuberculosis Granuloma T Cell Responses Exists, but a Balance of Pro- and Anti-inflammatory Cytokines Is Associated with Sterilization , 2015, PLoS pathogens.
[118] Vaccination Alters the Balance between Protective Immunity, Exhaustion, Escape, and Death in Chronic Infections , 2011, Journal of Virology.
[119] JoAnne L. Flynn,et al. Understanding Latent Tuberculosis: A Moving Target , 2010, The Journal of Immunology.
[120] L. Ramakrishnan,et al. The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection , 2009, Cell.
[121] M. Quail,et al. Tuberculous Granuloma Induction via Interaction of a Bacterial Secreted Protein with Host Epithelium , 2010, Science.
[122] Anna Huttenlocher,et al. Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish. , 2007, Cell host & microbe.
[123] Simeone Marino,et al. A Systems Biology Approach for Understanding Granuloma Formation and Function in Tuberculosis , 2013 .
[124] JoAnne L. Flynn,et al. Sterilization of granulomas is common in both active and latent tuberculosis despite extensive within-host variability in bacterial killing , 2013, Nature Medicine.
[125] Nicholas A Cilfone,et al. Strategies for Efficient Numerical Implementation of Hybrid Multi-scale Agent-Based Models to Describe Biological Systems , 2015, Cellular and molecular bioengineering.
[126] I. Orme,et al. CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis. , 2002, Cellular immunology.
[127] F. M. Gabhann,et al. Integration of experimental and computational approaches to sprouting angiogenesis , 2012, Current opinion in hematology.
[128] Rustom Antia,et al. Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination , 2015, Proceedings of the National Academy of Sciences.
[129] J. Flynn,et al. Aberrant TGF‐β signaling reduces T regulatory cells in ICAM‐1‐deficient mice, increasing the inflammatory response to Mycobacterium tuberculosis , 2009, Journal of leukocyte biology.
[130] Denise E. Kirschner,et al. Multi-Scale Modeling Predicts a Balance of Tumor Necrosis Factor-α and Interleukin-10 Controls the Granuloma Environment during Mycobacterium tuberculosis Infection , 2013, PloS one.
[131] Mohammad Fallahi-Sichani,et al. Differential Risk of Tuberculosis Reactivation among Anti-TNF Therapies Is Due to Drug Binding Kinetics and Permeability , 2012, The Journal of Immunology.
[132] E. Butcher,et al. T cell chemotaxis in a simple microfluidic device. , 2006, Lab on a chip.
[133] D. Woodland,et al. Early T‐cell responses in tuberculosis immunity , 2008, Immunological reviews.
[134] Simeone Marino,et al. Computational and Empirical Studies Predict Mycobacterium tuberculosis-Specific T Cells as a Biomarker for Infection Outcome , 2016, PLoS Comput. Biol..
[135] Jiezhong Chen,et al. Development and function of IL‐10 IFN‐γ‐secreting CD4+ T cells , 2009, Journal of leukocyte biology.
[136] C. Liao,et al. Quantifying the impact of drug combination regimens on TB treatment efficacy and multidrug resistance probability. , 2015, The Journal of antimicrobial chemotherapy.
[137] J. Koella,et al. Models of the within-host dynamics of persistent mycobacterial infections , 1996, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[138] J. Christian J. Ray,et al. Synergy between Individual TNF-Dependent Functions Determines Granuloma Performance for Controlling Mycobacterium tuberculosis Infection1 , 2009, The Journal of Immunology.
[139] Stewart T. Chang,et al. Effect of Multiple Genetic Polymorphisms on Antigen Presentation and Susceptibility to Mycobacterium tuberculosis Infection , 2008, Infection and Immunity.
[140] H. Viljoen,et al. Modeling nanoparticle delivery of TB drugs to granulomas. , 2016, Journal of theoretical biology.
[141] Peter J Dodd,et al. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling , 2016, PLoS medicine.
[142] John L. Johnson,et al. Population Pharmacokinetics of Levofloxacin, Gatifloxacin, and Moxifloxacin in Adults with Pulmonary Tuberculosis , 2007, Antimicrobial Agents and Chemotherapy.
[143] Kanury Rao,et al. Mathematical model of mycobacterium-host interaction describes physiology of persistence. , 2015, Journal of theoretical biology.
[144] R. Locksley,et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge , 2007, Nature Immunology.
[145] JoAnne L. Flynn,et al. Fate of Mycobacterium tuberculosis within Murine Dendritic Cells , 2001, Infection and Immunity.
[146] A. Barra,et al. Application of a Stochastic Modeling to Assess the Evolution of Tuberculous and Non-Tuberculous Mycobacterial Infection in Patients Treated with Tumor Necrosis Factor Inhibitors , 2013, PloS one.
[147] D. Kirschner,et al. Intracellular Bacillary Burden Reflects a Burst Size for Mycobacterium tuberculosis In Vivo , 2013, PLoS pathogens.
[148] C. Barry,et al. Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses , 2015, Immunological reviews.
[149] Jose L. Segovia-Juarez,et al. Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model. , 2004, Journal of theoretical biology.
[150] J. Flynn,et al. Cytotoxicity and Secretion of Gamma Interferon Are Carried Out by Distinct CD8 T Cells during Mycobacterium tuberculosis Infection , 2009, Infection and Immunity.
[151] N. Range,et al. Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania , 2015, PloS one.
[152] D. Kirschner,et al. Dynamics of co-infection with M. Tuberculosis and HIV-1. , 1999, Theoretical population biology.
[153] David Gammack,et al. A metapopulation model of granuloma formation in the lung during infection with mycobacterium tuberculosis. , 2005, Mathematical biosciences and engineering : MBE.
[154] Mats O. Karlsson,et al. Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption , 2008, Antimicrobial Agents and Chemotherapy.
[155] A. Rothchild,et al. In search of a new paradigm for protective immunity to TB , 2014, Nature Reviews Microbiology.
[156] D. Kirschner,et al. The human immune response to Mycobacterium tuberculosis in lung and lymph node. , 2004, Journal of theoretical biology.
[157] Denise E Kirschner,et al. Tuberculosis: global approaches to a global disease. , 2010, Current opinion in biotechnology.
[158] Denise Kirschner,et al. Harnessing the Heterogeneity of T Cell Differentiation Fate to Fine-Tune Generation of Effector and Memory T Cells , 2014, Front. Immunol..
[159] Ted Cohen,et al. Supplement S 1 , 2014 .
[160] Jin Hee Kim,et al. Microenvironments in Tuberculous Granulomas Are Delineated by Distinct Populations of Macrophage Subsets and Expression of Nitric Oxide Synthase and Arginase Isoforms , 2013, The Journal of Immunology.
[161] C. Demangel,et al. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin‐infected dendritic cells , 1999, European journal of immunology.
[162] Nicola Mulder,et al. A mathematical representation of the development of Mycobacterium tuberculosis active, latent and dormant stages. , 2012, Journal of theoretical biology.
[163] Avner Friedman,et al. Modeling the immune rheostat of macrophages in the lung in response to infection , 2009, Proceedings of the National Academy of Sciences.
[164] John Chan,et al. TNF Influences Chemokine Expression of Macrophages In Vitro and That of CD11b+ Cells In Vivo during Mycobacterium tuberculosis Infection1 , 2004, The Journal of Immunology.
[165] Chyung-Ru Wang,et al. Susceptibility of Mice Deficient in CD1D or TAP1 to Infection with Mycobacterium tuberculosis , 1999, The Journal of experimental medicine.
[166] Denise E Kirschner,et al. In silico models of M. tuberculosis infection provide a route to new therapies. , 2015, Drug discovery today. Disease models.
[167] I. Orme,et al. Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.
[168] E D Gilles,et al. Reduction of mathematical models of signal transduction networks: simulation-based approach applied to EGF receptor signalling. , 2004, Systems biology.
[169] NA Cilfone,et al. Systems Pharmacology Approach Toward the Design of Inhaled Formulations of Rifampicin and Isoniazid for Treatment of Tuberculosis , 2015, CPT: pharmacometrics & systems pharmacology.
[170] J. Flynn,et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.
[171] J. Flynn,et al. Immunology of tuberculosis. , 2003, Annual review of immunology.
[172] D. Kirschner,et al. A hybrid multi-compartment model of granuloma formation and T cell priming in tuberculosis. , 2011, Journal of theoretical biology.
[173] M. Tameris,et al. Modified vaccinia Ankara‐expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells , 2009, European journal of immunology.
[174] John Chan,et al. The timing of TNF and IFN-gamma signaling affects macrophage activation strategies during Mycobacterium tuberculosis infection. , 2008, Journal of theoretical biology.
[175] G. Guzzetta,et al. The Roles of Immune Memory and Aging in Protective Immunity and Endogenous Reactivation of Tuberculosis , 2013, PloS one.
[176] Mathematical Model of Oxygen Transport in Tuberculosis Granulomas , 2016, Annals of Biomedical Engineering.
[177] A. Myers,et al. CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection. , 2003, Immunity.
[178] Rustom Antia,et al. Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.
[179] Bruce R. Levin,et al. Two-Drug Antimicrobial Chemotherapy: A Mathematical Model and Experiments with Mycobacterium marinum , 2012, PLoS pathogens.
[180] F. M. Gabhann,et al. Systems Biology of Vascular Endothelial Growth Factors , 2008, Microcirculation.
[181] Daniel E. Zak,et al. A prospective blood RNA signature for tuberculosis disease risk , 2016, The Lancet.
[182] N. Chandra,et al. A systems perspective of host-pathogen interactions: predicting disease outcome in tuberculosis. , 2010, Molecular bioSystems.
[183] B. Palsson,et al. Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions , 2010, Molecular systems biology.
[184] J. Flynn,et al. Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[185] V. M. D. Martins dos Santos,et al. Systems-level modeling of mycobacterial metabolism for the identification of new (multi-)drug targets. , 2014, Seminars in immunology.
[186] Simeone Marino,et al. Dendritic Cell Trafficking and Antigen Presentation in the Human Immune Response to Mycobacterium tuberculosis 1 , 2004, The Journal of Immunology.
[187] C. Hamilton,et al. Strategies for Treating Latent Multiple-Drug Resistant Tuberculosis: A Decision Analysis , 2012, PloS one.
[188] M. Tameris,et al. First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults. , 2015, Vaccine.
[189] D. Born,et al. Mycobacterium marinum Infection of Adult Zebrafish Causes Caseating Granulomatous Tuberculosis and Is Moderated by Adaptive Immunity , 2006, Infection and Immunity.